Page last updated: 2024-11-02

pd 98059 and Kidney Diseases

pd 98059 has been researched along with Kidney Diseases in 3 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, CR1
Luo, SG1
Lin, X1
Wang, J1
Liu, Y1
Choi, DE1
Jeong, JY1
Lim, BJ1
Chung, S1
Chang, YK1
Lee, SJ1
Na, KR1
Kim, SY1
Shin, YT1
Lee, KW1
Bell, HL1
Gööz, M1

Other Studies

3 other studies available for pd 98059 and Kidney Diseases

ArticleYear
Silenced miR-21 inhibits renal interstitial fibrosis via targeting ERK1/2 signaling pathway in mice.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:3 Suppl

    Topics: Actins; Animals; Cell Line; Disease Models, Animal; Fibrosis; Flavonoids; Humans; Kidney Diseases; M

2019
Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:2

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Caspase 3; Creatinine; Cyclic G

2009
ADAM-17 is activated by the mitogenic protein kinase ERK in a model of kidney fibrosis.
    The American journal of the medical sciences, 2010, Volume: 339, Issue:2

    Topics: ADAM Proteins; ADAM17 Protein; Animals; Fibrosis; Flavonoids; Gene Expression Regulation; Kidney Dis

2010